Live Breaking News & Updates on Vanguard Health Care Fund

Stay updated with breaking news from Vanguard health care fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PRIMECAP Management Bolsters Stake in Biogen Inc

PRIMECAP Management (Trades, Portfolio) has recently increased its investment in Biogen Inc (NASDAQ:BIIB), a notable move that underscores the firm's confidence in the biotechnology company. The addition has adjusted PRIMECAP Management (Trades, Portfolio)'s position in Biogen Inc to 3.55% of its portfolio, representing an 11.22% stake in the company. ....

United States , Biogen Inc Financial Health , T Rowe Price Equity Income Fund , Other Notable Investors In Biogen Inc , Biogen Inc , Overview Of Biogen Inc , Vanguard Health Care Fund , Gf Score Of Biogen Inc , Financial Health , Financial Strength , Profitability Rank , Drug Manufacturers , Notable Investors , Ken Fisher , Joel Greenblatt , Primecap Management , Investment Philosophy , Biotechnology Company ,

Fortrea Stock: High Risk And Low Upside Potential (NASDAQ:FTRE)

Fortrea Stock: High Risk And Low Upside Potential (NASDAQ:FTRE)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Clinical Services , Iqvia Holdings Inc , Contract Research , Vanguard Health Care Fund , Enabling Services , Thermo Fisher Scientific , Quarterly Backlog , Profit Margin , Seeking Alpha , Fortrea June , Fortrea Investor , Fortrea November , Free Cash Flow ,

HQH: Disappointing Track Record (NYSE:HQH)

HQH: Disappointing Track Record (NYSE:HQH)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Fidelity Select Health Care Services Portfolio , Vanguard Health Care Fund , Oculis Holding , Health Care Select Sector , Big Pharma , Healthcare Investors , Tekla Capital Management , Price Target , Net Margin , Teka Capital ,

Baillie Gifford Bolsters Stake in Moderna Inc

Baillie Gifford (Trades, Portfolio), a renowned investment management firm, has recently increased its investment in Moderna Inc (NASDAQ:MRNA), a leader in the biotechnology industry. This transaction has brought Baillie Gifford (Trades, Portfolio)'s total share count in Moderna to 45,654,527, representing a significant position size of 3.33% in the firm's portfolio and 11.97% of the firm's holdings in the traded stock. ....

United States , Moderna Inc , Vanguard Health Care Fund , Jefferies Group , Baillie Gifford , Growth Rank , Profitability Rank , Consumer Cyclical , Notable Investors , Health Care Fund , Ron Baron , Joel Greenblatt , Moderna Inc , Nvestment Management Firm , Biotechnology Industry ,

Baillie Gifford Adjusts Stake in Alnylam Pharmaceuticals

On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, made a significant adjustment to its investment portfolio by reducing its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY). The transaction involved the sale of 1,196,042 shares, which resulted in a 14.65% decrease in Baillie Gifford (Trades, Portfolio)'s holdings in the company. ....

Alnylam Pharmaceuticals , Other Notable Investors In Alnylam Pharmaceuticals , Alnylam Pharmaceutical , Jefferies Group , Vanguard Health Care Fund , Financial Health Of Alnylam Pharmaceuticals , Baillie Gifford , Growth Rank , Financial Strength , Profitability Ranks , Consumer Cyclical , Notable Investors , Health Care Fund , Joel Greenblatt , Alnylam Pharmaceuticals , Nvestment Management Firm , Investment Portfolio , Biotech Company ,